Equities

Enzon Pharmaceuticals Inc

Enzon Pharmaceuticals Inc

Actions
  • Price (USD)0.076
  • Today's Change0.005 / 6.89%
  • Shares traded17.21k
  • 1 Year change-33.48%
  • Beta0.5138
Data delayed at least 15 minutes, as of Nov 22 2024 20:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Enzon Pharmaceuticals Inc (ENZN:QXR) traded at 0.076, 26.67% above the 52 week low of 0.06 set on Apr 01, 2024.
52-week range
Today
0.06Apr 01 20240.24Jun 10 2024
Open0.0756
High0.08
Low0.0756
Bid--
Offer--
Previous close0.0711
Average volume14.96k
Shares outstanding74.21m
Free float66.17m
P/E (TTM)21.35
Market cap5.28m USD
EPS (TTM)0.0033
USD
Data delayed at least 15 minutes, as of Nov 22 2024 20:17 GMT.
More ▼

Events & Activity

  • ENZN:QXR trading volume exceeds daily average by +101.53%
  • ENZN:QXR price moved over -12.20% to 0.072
  • ENZN:QXR price rises above 15-day moving average to 0.08 at 10:37 GMT
  • ENZN:QXR price rises above 15-day moving average to 0.0819 at 12:04 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.